Aptevo Therapeutics (APVO) Q1 2025 Earnings

Feb 14Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-21.09
-14.62
-8.14
-1.67

Details

Expected EPS
-7.75
Actual EPS
-8.94
Surprise EPS
-1.19
Surprise Percent
-15.35%

Description

⁨Aptevo Therapeutics⁩ (⁦APVO⁩) has reported earnings of ⁦-8.94⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts